MORE►
taysha gene therapies
[Image: Chinnawat Ngamsom/iStock]
Here Are the Winners of The Innovation Awards 2023
by Lance Murray | Jan 17, 2023
Dallas Innovates and D CEO celebrated 68 honorees and revealed the winners of our fourth-annual Innovation Awards at an event held at On the Levee in the Dallas Design District.
Here's a full list of winners and finalists.
by Quincy Preston |
Dec 19, 2022
Dallas-based Taysha Gene Therapies is starting a new chapter in its fight to tackle devastating neurological conditions with changes in its top executive leadership.
Late Friday, the publicly traded biotech announced that Sean P....
MORE►
by Lance Murray |
Nov 3, 2022
Now in its fourth year, the program from Dallas Innovates and D CEO honors 68 disruptors and trailblazers driving a new vision for innovation in North Texas.
Finalists will be recognized in the January/February issue of D CEO magazine and online at DallasInnovates.com. Winners will be revealed at an exclusive awards event in January.
MORE►
by Kevin Cummings |
Oct 28, 2022
In this week’s North Texas deal flow, you’ll also find news about Taysha Gene Therapies landing a $50M investment; music tech startup MAX’s Series B raise; Dallas Venture Capital’s latest investment; Tyler Technologies’ $68M acquisition of Rapid Financial Solutions; NaturalShrimp hitting the Nasdaq Capital Market; and more.
MORE►
Pegasus artwork in the lobby of Dallas' Pegasus Park [Photo: Dallas Innovates]
Center of Gravity: Capital Factory Kicks Off New Dallas Digs With Startup Crawl and Health Supernova Event
by Kevin Cummings | May 6, 2022
Earlier this week, the Austin-based accelerator and investor announced its plans to launch a Center for Health Innovation at Pegasus Park in Dallas.
MORE►
by Kevin Cummings |
Apr 15, 2022
What companies are finding funding or having a big exit? From startup investments to grants and acquisitions, Dallas Innovates tracks what’s happening in North Texas money.
MORE►
by David Kirkpatrick |
Jan 25, 2022
The accelerator will move this summer from its downtown Dallas location to 6,000 square feet of collaborative and flexible office space in Pegasus Park's 18-story tower.
Just weeks ago, Pegasus Park landed one of its biggest tenants to date: UT Southwestern‘s Office for Technology Development and other UTSW entities will be leasing six floors in the tower.
MORE►
by Dallas Innovates | Staff Report |
Oct 26, 2021
Now in its third year, the program from Dallas Innovates and D CEO honors 78 disruptors and trailblazers driving a new vision for innovation in North Texas.
MORE►
R.A. Session II
Success in the Genes: Launching in a Pandemic Didn’t Hurt This Fast-Growth Dallas Biotech Company
by Quincy Preston | Feb 26, 2021
In under six months, Taysha Gene Therapies rocketed from the unveiling of its UTSW spinout to a $157 million initial public offering. We talk with Founder and CEO R.A. Session II about the biotech with big plans.
MORE►
by Quincy Preston and Sandra Engelland |
Feb 24, 2021
With an entrepreneurial mindset, Aldridge turns scientific discoveries into real-world solutions. Here's how Aldridge is playing a large role in making Dallas a destination for biotech and life sciences.
MORE►
by Alex Edwards |
Jan 13, 2021
The expanded alliance between Taysha and UTSW, which dates back to when Taysha emerged from stealth in April 2020, will support the discovery of novel gene therapy candidates and technologies in new disease areas.
MORE►
![R.A. Session II, president, CEO, and founder of Taysha Gene Therapies [Background image: Olena Yepifanova via iStock]](https://s24806.pcdn.co/wp-content/uploads/2020/04/TayshaGene-Session-970-1-360x203.jpg)
by Quincy Preston and Alex Edwards |
Aug 5, 2020
Taysha Gene Therapies, which was been operating in stealth with UT Southwestern until this April, plans to use the financing to advance its initial cohort of lead programs into its clinic. By the end of 2021, Taysha expects to file four Investigational New Drug applications.
MORE►
